title: Thalidomide in Refractory Crohn's Disease: Risk-Benefit Ratio.
authors.affiliation: Section of Pediatric Gastroenterology, Department of Pediatrics, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
authors.forename: Wael
authors.initials: W
authors.lastname: El-Matary
mesh_terms: D000328:Adult; D003424:Crohn Disease; D006801:Humans; D007166:Immunosuppressive Agents; D016017:Odds Ratio; D012306:Risk; D013792:Thalidomide
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide